Search

everythinglearnresearchcommunity

for

Search:↓

Skin side effects from CDK4/6 inhibitors in breast cancer patients are generally mild and treatable, allowing most patients to continue treatment.

Immunotherapy for cancer caused a patient to develop a condition affecting hormone production, requiring ongoing hormone replacement therapy.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

Tissue-resident memory T cells can protect against infections and cancer but may also contribute to autoimmune diseases.

Radiation therapy damages skin structure and immune function, causing inflammation and potential hair loss.

Benign follicular mucinosis involves immune cells attacking hair follicles.

Cellular and immunotherapies show promise for healing chronic wounds but need more research.

Autophagy helps keep skin healthy and may improve treatments for skin diseases.

Melanoma's complexity requires personalized treatments due to key genetic mutations and tumor-initiating cells.

Tadalafil and Finasteride may help treat aggressive melanoma.

Scalp melanoma, a deadly skin cancer, is often found late due to its hard-to-see location, especially in older men. Early detection, possible treatments, and the role of hairdressers in spotting it early are discussed. More research is needed to improve detection and treatment.

Propylthiouracil can cause hair loss, reduced sweating, and nail issues, but stopping the drug can reverse hair and nail problems.

Treg dysfunction is linked to various autoimmune skin diseases, and understanding Treg properties is key for new treatments.

The document concludes that systemic therapy is becoming more important in treating head and neck cancer, with new treatments showing promise.

Contact immunotherapy might help treat various skin conditions, but more research is needed to confirm its safety and effectiveness.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

Advanced nanocarrier and microneedle drug delivery methods are more effective, safer, and less invasive for treating skin diseases.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

Certain foods and supplements can help treat skin diseases alongside medication.

Most pediatric cancer patients in the study developed skin problems, often due to their cancer treatment.

A group has developed therapies that show promise for treating cancer and various other conditions.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

The review emphasizes the need to recognize skin conditions that affect hair follicles and sweat glands to avoid misdiagnosis.

Red clover extract-based scalp treatments significantly improved hair volume and reduced hair loss and damage.

The AI model somewhat predicts lymph node status in melanoma patients using skin sample images.

Some drugs can cause changes to your hair.

Preventive measures and effective management are crucial for reducing skin side effects in cancer treatment.

Low ferritin, vitamin D deficiency, and thyroid problems may contribute to hair loss in some hospital patients in Western Saudi Arabia.

New cancer treatments aim to reduce side effects and improve effectiveness.